Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

A RadNet insider disclosed selling 15,000 shares for approximately $932,000 on March 18, 2026. All shares transacted were held directly by Greg Sorensen, with no indirect or derivative activity disclosed.

RadNet, Inc. (RDNT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

RadNet combines a scaled outpatient imaging platform with DeepHealth. This is their AI-enabled radiology software segment that adds growth optionality. RDNT's core imaging demand also remains strong, helped by outpatient site-of-care trends, but their acquisitions and hospital joint ventures are part of the story. Management reported record Q4 2025 revenue, while underlying organic growth suggests the base imaging business is still healthy.

RadNet, Inc. (RDNT) GLEAMER SAS - M&A Call Transcript

LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, reminds investors that on Thursday, March 5, 2026, investors are invited to join a dedicated conference call and presentation to hear more details about the recently completed acquisition of Gleamer SAS and RadNet's Digital Health strategy. On the call, investors will also have the opportunity to ask questions of executive management.

Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gain strong traction. Cidara Therapeutics' shares rose further following Merck's acquisition of the company in a $9.2 billion all-cash deal announced in November 2025, representing a premium of more than 100% over the prior closing price. Doximity's stock detracted from performance as the company issued disappointing guidance for the next two quarters.

RadNet, Inc. (RDNT) Q4 2025 Earnings Call Transcript